Updated May. 7, 2013 at 11:05 a.m.

Premium Lock BioCryst reports progress for rare disease drug

Published: 2013-05-07 11:00:00
Updated: 2013-05-07 11:05:07

BioCryst BioCryst

BioCryst is studying a compound to treat hereditary angiodema, a rare genetic disease. Read more about the company's progress with the compound....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders